Resource Centers
- FDA Expert Panel Declines to Endorse New Influenza Vaccine
- H1N1 Flu Wave Peaking in US?
- Children's Hearing Loss From Cisplatin Chemotherapy Associated With Gene Variants
- ACOG Issues Revised Cervical Cancer Screening Guidelines
- Alert Cardiologists Shocked by New FDA Alert on Clopidogrel-PPI Interaction
Medscape Journals
Specialty Spotlight
-
A Case of Indurated Skin Rash in a Transplant Patient
-
Video Day in Review from AHA 2009 with Dr. Melissa Walton-Shirley: Tuesday, November 17
-
Examining the Ears, Nose, and Oral Cavity in the Older Patient
-
What Should Patients Do With Unused Narcotics?
-
Do Pacifiers Interfere With Breastfeeding Success?
Medscape Community Resources
- Video Day in Review from AHA 2009 with Dr. Melissa Walton-Shirley: Tuesday, November 17
- What Should Patients Do With Unused Narcotics?
- Do Pacifiers Interfere With Breastfeeding Success?
- Video Day in Review from AHA 2009 with Dr. Melissa Walton-Shirley: Monday, November 16
- Plasma HIV RNA is a Risk Factor for Non-Hodgkin's Lymphoma
POLL
New legislation in the House would reform the formula for Medicare reimbursements to physicians and prevent a 21.2% pay cut scheduled for 2010. The legislation would temporarily base reimbursements on the Medicare Economic Index, which measures inflation in physician-practice costs. Do you favor or oppose this new legislation?
- A Treatment Option for Atrial Fibrillation
- A single medication with 4 indications
- A treatment option for ACS and DVT/PE
- ABILIFY® (aripiprazole)
- ACUVUE® Brand Contact Lenses
- ADHD treatment: Efficacy, insights, and dosing
- ALIMTA® (pemetrexed for injection)
- AMBIEN CR® (zolpidem tartrate extended-release CIV)
- Argatroban
- Atrial Fibrillation Condition Site
- COSAMIN®DS
- CRESTOR® (rosuvastatin calcium)
- Carac® (fluorouracil cream 0.5%)
- Ciprodex® (ciprofloxacin 0.3% and dexamethasone 0.1%) Sterile Otic Suspension
- Clinical Management Center
- DanActive® and ACTIVIA® Information Center
- Diabetes in America
- ENABLEX® (darifenacin) Extended-Release Tablets 7.5 mg or 15 mg
- Epilepsy360: Connections in Care
- GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]
- GEMZAR® (gemcitabine HCI)
- GEODON® (ziprasidone HCI)
- Genomic Advances in Cardiovascular Care
- Heartmate II® Left Ventricular Assist System
- IL-6 and Rheumatoid Arthritis
- ISENTRESS® (raltegravir) Tablets
- Kidney Transplantation
- LEVAQUIN® (levofloxacin) tablets/injection
- LOVAZA® (omega-3-acid ethyl esters)
- NEW INTUNIV" (guanfacine) Extended Release Tablets
- NUCYNTA™ (tapentadol)
- NUVIGIL® (armodafinil) Tablets [C-IV]
- Navigenics® Genetic Risk Assessment Services
- Neuroendocrine tumors: Increasing in incidence and easy to overlook
- Neutrogena® Pure & Free" Baby Sunblock Lotion
- OPTIMAL Forum"
- Onglyza" (saxagliptin) InfoSite
- PEGASYS (peginterferon alfa-2a) for injection
- PREMARIN® (conjugated estrogens tablets, USP)
- PRISTIQ® (desvenlafaxine)
- ProAir® HFA
- Professional Liability Risk: Facts, Perspectives, and Management Strategies InfoSite
- QuickVue® Influenza A+B Test
- REBIF® (interferon beta-1a)
- RITUXAN® (Rituximab)
- Reclast® (zoledronic acid) injection
- Research VEGF: Emerging Research Around Targeting VEGF
- Risk of Osteoporosis
- SANDOSTATIN® LAR DEPOT (octreotide acetate for injectable suspension)
- Survivorship and Early Breast Cancer Information
- Symbyax® (Olanzapine and Fluoxetine HCl Capsules)
- TOVIAZ® (fesoterodine fumarate)
- Talecris Hypermunes™
- Targeted Biologic Therapy in Breast Cancer
- Targeting CD20: Scientific Insights and Implications for Therapy
- The HER signaling network and cancer
- The Pain Institute
- The Science of Facial Aging
- Treatment of Pulmonary Arterial Hypertension
- VESIcare (solifenacin succinate) tablets
- VIGAMOX® solution
- Vyvanse (lisdexamfetamine dimesylate)
- XYZAL® (levocetirizine dihydrochloride)
